AbbVie, EADV 2026, Dermatology, Immune-Mediated Skin Diseases, Atopic Dermatitis, Psoriasis, Hidradenitis Suppurativa

Chicago, Illinois, U.S., September 30, 2026 AbbVie is presenting new clinical and real-world evidence across multiple immune-mediated skin diseases...